ConductScience.org, home

Gene · 29116

MYLIP: myosin regulatory light chain interacting protein

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MYLIP: myosin regulatory light chain interacting protein. Genes, record 29116. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/29116

On this page

Gene

Symbol
MYLIP
HGNC
Name
myosin regulatory light chain interacting protein
HGNC
NCBI Gene ID
29116
NCBI Gene
HGNC ID
HGNC:21155
HGNC
Ensembl
ENSG00000007944
NCBI Gene
Aliases
IDOL, MIR
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q8WY64E3 ubiquitin-protein ligase MYLIP44535Ensembl, GeneID, HGNC

Source UniProt

Patents22

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1454635Q8WY64Espacenet
EP 4650780 A22025-11-197355Q8WY64Espacenet
EP 4641202 A22025-10-295259Q8WY64Espacenet
JP 2025517970 A2025-06-127355Q8WY64Espacenet
JP 2025032204 A2025-03-1131957Q8WY64Espacenet
KR 1020250017231 A2025-02-045259Q8WY64Espacenet
EP 4461818 A22024-11-1331957Q8WY64Espacenet
KR 1020230125856 A2023-08-291804Q8WY64Espacenet
JP 2023058610 A2023-04-2531957Q8WY64Espacenet
JP 2023510565 A2023-03-1467Q8WY64Espacenet

1 to 10 of 22

See all 22 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,014

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMYLIP papersNewest fiscal year
P30DK063491Diabetes Research Center (DRC)72025
P30CA016672Cancer Center Support Grant62025
P30CA016058Cancer Center Support Grant52025
ZIAHL006001Framingham Project/Levy42025
P30CA016087Cancer Center Support Grant32025
P30CA023074University of Arizona Cancer Center - Cancer Center Support Grant32025
P30CA023108Cancer Center Support Grant32025
P30CA068485Cancer Center Support Grant32025
P30ES019776HERCULES: Exposome Research Center32025
P50CA127001SPORE in Brain Cancer32025

1 to 10 of 1,014Source NIH's project files

See all 1,014 nih grants

Papers1,569

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
The E3 ubiquitin ligase IDOL suppresses PRRSV replication by targeting viral Nsp3 for SQSTM1-mediated selective autophagic degradation.mBio202642742217PubTator, text miningPubMed
Genome-wide CRISPR screens identify an RXR-MYLIP-LDLR axis regulating BH3 mimetic sensitivity in peripheral T-cell lymphomas.Oncogene202642642488PubTator, text miningPubMed
MYLIP-dependent ubiquitination and degradation of LDLR in acute myeloid leukemia and MAPK signaling.Mol Cell Probes202642235836PubTator, text miningPubMed
Lipid Metabolism and Oxidative Stress in Uterine Corpus Endometrial Carcinoma: Prognostic and Immune Landscape Analysis.Asia Pac J Clin Oncol202641942838PubTator, text miningPubMed
LncRNA SNHG25 promotes proliferation, migration, and invasion of acute myeloid leukemia by competitively binding to miR-205-5p.Clin Exp Med202641865170PubTator, text miningPubMed
Functional interrogation of candidate cis-regulatory elements at the LDLR locus.PLoS Genet202641843552PubTator, text miningPubMed
Validated comprehensive RP HPLC approach for separation and quantification of solifenacin and mirabegron in the presence of their degradation products.Sci Rep202641826414PubTator, text miningPubMed
The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities.MedComm (2020)202641799937PubTator, text miningPubMed
PCSK9-mediated degradation of cell-surface LDL receptors impairs human CD8+ T cell effector functions.iScience202641767258PubTator, text miningPubMed
Let-7a and miR-34a Interplay Potent Suppressive Roles in Hepatocellular Carcinoma via Co-Targeting FNDC3B, IGF2 and SOX4.Int J Mol Sci202641751849PubTator, text miningPubMed

1 to 10 of 1,569

See all 1,569 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/29116

GET https://conductscience.org/api/genes/v1/29116/patents?page=2